FDA Clearance Tracker · P130008-S056
Inspire Programmer System
Last checked: Nov 20, 2026Latest source record: Feb 12, 2021 (this decision)Source: openFDAMethods & limitations
Decided
Feb 12, 2021
Approved
Time to decision
196 days
Received Jul 31, 2020. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P130008-S056
- Device name
- Inspire Programmer System
- Applicant
- Inspire Medical Systems
- Applicant location
- Maple Grove, MN
- Received
- Jul 31, 2020
- Decided
- Feb 12, 2021
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P130008
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval for:1) Updated version of the Model 2740 Inspire Programmer System;2) Minor software changes to the Application Module (AM)/Tablet;3) Manufacturing process changes to reduce scrap for the new programmer cable;4) Changes to improve aesthetics of the programmer cable; and5) Minor software updates regarding non-English languages for the European market and minor bug fixes.
Source documents
Other decisions for Inspire Medical Systems
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Inspire Upper Airway Stimulation SystemPMA supplement
P130008-S090 · Decided Jun 8, 2023 · 234 days after receipt · Panel Track
Device type: Stimulator, hypoglossal nerve, implanted, apnea (MNQ) · Anesthesiology & Respiratory
2 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.